BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 494318 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC=C)C(=O)OC InChI=1S/C26H23N3O2/c1-4-14-29-24-13-11-18(26(30)31-3)16-21(24)27-25(29)17-10-12-23-20(15-17)19-8-6-7-9-22(19)28(23)5-2/h4,6-13,15-16H,1,5,14H2,2-3H3 MMZFRHDNEKNLQA-UHFFFAOYSA-N 261749 Methyl 1-allyl-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylate::US9708311, 1 Prostaglandin E2 receptor EP4 subtype Homo sapiens 3100 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261749&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281182 376223587 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494319 CCOC(=O)c1ccc(NCCOC)c(c1)[N+]([O-])=O InChI=1S/C12H16N2O5/c1-3-19-12(15)9-4-5-10(13-6-7-18-2)11(8-9)14(16)17/h4-5,8,13H,3,6-7H2,1-2H3 YVBURBOSAMMNRR-UHFFFAOYSA-N 261750 Ethyl 4-[(2-methoxyethyl)amino]-3-nitrobenzoate::US9708311, 2 Prostaglandin E2 receptor EP4 subtype Homo sapiens 312 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261750&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 16003602 376223588 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494320 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)OC InChI=1S/C26H25N3O3/c1-4-28-22-8-6-5-7-19(22)20-15-17(9-11-23(20)28)25-27-21-16-18(26(30)32-3)10-12-24(21)29(25)13-14-31-2/h5-12,15-16H,4,13-14H2,1-3H3 HNKQOIMXIKNLQZ-UHFFFAOYSA-N 261751 Methyl 2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylate::US9708311, 3 Prostaglandin E2 receptor EP4 subtype Homo sapiens 175 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261751&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281450 376223589 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494321 COCCNc1ccc(cc1N)C(O)=O InChI=1S/C10H14N2O3/c1-15-5-4-12-9-3-2-7(10(13)14)6-8(9)11/h2-3,6,12H,4-5,11H2,1H3,(H,13,14) YMXVSYRCBLIMJP-UHFFFAOYSA-N 261752 3-Amino-4-[(2-methoxyethyl)amino]benzoic acid::US9708311, 4 Prostaglandin E2 receptor EP4 subtype Homo sapiens 5.59 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261752&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 11514002 376223590 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494322 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(=O)OC InChI=1S/C27H25N3O2/c1-3-29-23-7-5-4-6-20(23)21-14-18(10-12-24(21)29)26-28-22-15-19(27(31)32-2)11-13-25(22)30(26)16-17-8-9-17/h4-7,10-15,17H,3,8-9,16H2,1-2H3 HIJRXRGAZYBOEJ-UHFFFAOYSA-N 261753 Methyl 1-(cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylate::US9708311, 5 Prostaglandin E2 receptor EP4 subtype Homo sapiens 404 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261753&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281451 376223591 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494323 [O-][N+](=O)c1c(Cl)c(Br)ccc1NCC1CC1 InChI=1S/C10H10BrClN2O2/c11-7-3-4-8(13-5-6-1-2-6)10(9(7)12)14(15)16/h3-4,6,13H,1-2,5H2 MIFUMACGENVJCR-UHFFFAOYSA-N 261754 4-Bromo-3-chloro-N-(cyclopropylmethyl)-2-nitroaniline::US9708311, 6 Prostaglandin E2 receptor EP4 subtype Homo sapiens 14.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261754&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202347 376223592 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494324 Nc1c(Cl)c(Br)ccc1NCC1CC1 InChI=1S/C10H12BrClN2/c11-7-3-4-8(10(13)9(7)12)14-5-6-1-2-6/h3-4,6,14H,1-2,5,13H2 JEPQWAXSTTVKQP-UHFFFAOYSA-N 261755 4-Bromo-3-chloro-N1-(cyclopropylmethyl)benzene-1,2-diamine::US9708311, 7 Prostaglandin E2 receptor EP4 subtype Homo sapiens 1430 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261755&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202459 376223593 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494325 CCn1c2ccccc2c2cc(ccc12)-c1nc2c(Cl)c(Br)ccc2n1CC1CC1 InChI=1S/C25H21BrClN3/c1-2-29-20-6-4-3-5-17(20)18-13-16(9-11-21(18)29)25-28-24-22(12-10-19(26)23(24)27)30(25)14-15-7-8-15/h3-6,9-13,15H,2,7-8,14H2,1H3 KTNMFGPDXMSNOH-UHFFFAOYSA-N 261756 3-[5-Bromo-4-chloro-1-(cyclopropylmethyl)-1H-benzimidazol-2-yl]-9-ethyl-9H-carbazole::US9708311, 8 Prostaglandin E2 receptor EP4 subtype Homo sapiens 19.7 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261756&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202620 376223594 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494326 COC(=O)c1ccc(NCC2CC2)c(N)c1C InChI=1S/C13H18N2O2/c1-8-10(13(16)17-2)5-6-11(12(8)14)15-7-9-3-4-9/h5-6,9,15H,3-4,7,14H2,1-2H3 ZILYONQYJPEBGA-UHFFFAOYSA-N 261757 Methyl 3-amino-4-[(cyclopropylmethyl)amino]-2-methylbenzoate::US9708311, 9 Prostaglandin E2 receptor EP4 subtype Homo sapiens 71.2 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261757&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202385 376223595 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494327 CCn1c2ccc(cc2c2ccc(F)cc12)-c1nc2cc(ccc2n1CCOC)C(O)=O InChI=1S/C25H22FN3O3/c1-3-28-21-8-4-15(12-19(21)18-7-6-17(26)14-23(18)28)24-27-20-13-16(25(30)31)5-9-22(20)29(24)10-11-32-2/h4-9,12-14H,3,10-11H2,1-2H3,(H,30,31) YPARQYYRYUEBHJ-UHFFFAOYSA-N 261759 2-(9-Ethyl-7-fluoro-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 10 Prostaglandin E2 receptor EP4 subtype Homo sapiens 10.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261759&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281180 376223597 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494328 CCn1c2ccc(cc2c2c(F)cccc12)-c1nc2cc(ccc2n1CCOC)C(O)=O InChI=1S/C25H22FN3O3/c1-3-28-20-9-7-15(13-17(20)23-18(26)5-4-6-22(23)28)24-27-19-14-16(25(30)31)8-10-21(19)29(24)11-12-32-2/h4-10,13-14H,3,11-12H2,1-2H3,(H,30,31) GLUVBPUPVTVFNT-UHFFFAOYSA-N 261760 2-(9-Ethyl-5-fluoro-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 11 Prostaglandin E2 receptor EP4 subtype Homo sapiens 6.36 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261760&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281454 376223598 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494329 CCn1c2ccc(cc2c2cccc(F)c12)-c1nc2cc(ccc2n1CCOC)C(O)=O InChI=1S/C25H22FN3O3/c1-3-28-21-9-7-15(13-18(21)17-5-4-6-19(26)23(17)28)24-27-20-14-16(25(30)31)8-10-22(20)29(24)11-12-32-2/h4-10,13-14H,3,11-12H2,1-2H3,(H,30,31) ZCGHJEMCRFWOER-UHFFFAOYSA-N 261761 2-(9-Ethyl-8-fluoro-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 12 Prostaglandin E2 receptor EP4 subtype Homo sapiens 10.2 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261761&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281452 376223599 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494330 CCn1c2ccc(C=O)cc2c2c(F)cccc12 InChI=1S/C15H12FNO/c1-2-17-13-7-6-10(9-18)8-11(13)15-12(16)4-3-5-14(15)17/h3-9H,2H2,1H3 HSLAUYBXAVNZJY-UHFFFAOYSA-N 261762 9-Ethyl-5-fluoro-9H-carbazole-3-carbaldehyde::US9708311, 13 Prostaglandin E2 receptor EP4 subtype Homo sapiens 18.0 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261762&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202334 376223600 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494331 CCn1c2ccccc2c2cc(cnc12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C25H22N4O2/c1-2-28-21-6-4-3-5-18(21)19-11-17(13-26-24(19)28)23-27-20-12-16(25(30)31)9-10-22(20)29(23)14-15-7-8-15/h3-6,9-13,15H,2,7-8,14H2,1H3,(H,30,31) PEMKEFCIURPVDU-UHFFFAOYSA-N 261763 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-pyrido[2,3-b]indol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 14 Prostaglandin E2 receptor EP4 subtype Homo sapiens 33.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261763&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202704 376223601 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494332 COCCn1c2ccccc2c2cc(C=O)ccc12 InChI=1S/C16H15NO2/c1-19-9-8-17-15-5-3-2-4-13(15)14-10-12(11-18)6-7-16(14)17/h2-7,10-11H,8-9H2,1H3 OWBJOFDSJOOCDX-UHFFFAOYSA-N 261764 9-(2-Methoxyethyl)-9H-carbazole-3-carbaldehyde::US9708311, 15 Prostaglandin E2 receptor EP4 subtype Homo sapiens 23.8 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261764&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202410 376223602 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494333 CCn1c2ccc(OC)cc2c2cc(C=O)ccc12 InChI=1S/C16H15NO2/c1-3-17-15-6-4-11(10-18)8-13(15)14-9-12(19-2)5-7-16(14)17/h4-10H,3H2,1-2H3 LQHBVBHGTLVILP-UHFFFAOYSA-N 261765 9-Ethyl-6-methoxy-9H-carbazole-3-carbaldehyde::US9708311, 16 Prostaglandin E2 receptor EP4 subtype Homo sapiens 28.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261765&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 21087564 376223603 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494334 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1cccc(Cl)c1 InChI=1S/C31H27ClN4O4S/c1-3-35-27-10-5-4-9-24(27)25-17-20(11-13-28(25)35)30-33-26-18-21(12-14-29(26)36(30)15-16-40-2)31(37)34-41(38,39)23-8-6-7-22(32)19-23/h4-14,17-19H,3,15-16H2,1-2H3,(H,34,37) PNXYQMGEPAVSCI-UHFFFAOYSA-N 261766 N-[(3-Chlorophenyl)sulphonyl]-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 17 Prostaglandin E2 receptor EP4 subtype Homo sapiens 14.7 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261766&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281723 376223604 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494335 CCn1c2ccccc2c2nc(Cl)ccc12 InChI=1S/C13H11ClN2/c1-2-16-10-6-4-3-5-9(10)13-11(16)7-8-12(14)15-13/h3-8H,2H2,1H3 IIFZHMAVRMYNFT-UHFFFAOYSA-N 261767 2-Chloro-5-ethyl-5H-pyrido[3,2-b]indole::US9708311, 18 Prostaglandin E2 receptor EP4 subtype Homo sapiens 22.8 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261767&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202342 376223605 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494336 CCn1c2ccccc2c2nc(ccc12)C(=O)OC InChI=1S/C15H14N2O2/c1-3-17-12-7-5-4-6-10(12)14-13(17)9-8-11(16-14)15(18)19-2/h4-9H,3H2,1-2H3 KUQKMCQSDUDHMJ-UHFFFAOYSA-N 261768 Methyl 5-ethyl-5H-pyrido[3,2-b]indole-2-carboxylate::US9708311, 19 Prostaglandin E2 receptor EP4 subtype Homo sapiens 32.2 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261768&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202408 376223606 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494337 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)CCc1ccc(cc1)C(F)(F)F InChI=1S/C34H31F3N4O4S/c1-3-40-29-7-5-4-6-26(29)27-20-23(10-14-30(27)40)32-38-28-21-24(11-15-31(28)41(32)17-18-45-2)33(42)39-46(43,44)19-16-22-8-12-25(13-9-22)34(35,36)37/h4-15,20-21H,3,16-19H2,1-2H3,(H,39,42) FDKVDAZZAMSNTB-UHFFFAOYSA-N 261769 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-({2-[4-(trifluoromethyl)phenyl]ethyl}-sulphonyl)-1H-benzimidazole-5-carboxamide::US9708311, 20 Prostaglandin E2 receptor EP4 subtype Homo sapiens 683 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261769&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281990 376223607 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494338 CCn1c2ccccc2c2cc(cnc12)C#N InChI=1S/C14H11N3/c1-2-17-13-6-4-3-5-11(13)12-7-10(8-15)9-16-14(12)17/h3-7,9H,2H2,1H3 LJTRTRAEOIPFTK-UHFFFAOYSA-N 261770 9-Ethyl-9H-pyrido[2,3-b]indole-3-carbonitrile::US9708311, 21 Prostaglandin E2 receptor EP4 subtype Homo sapiens 103 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261770&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202451 376223608 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494339 CCn1c2ccccc2c2cc(C=O)cnc12 InChI=1S/C14H12N2O/c1-2-16-13-6-4-3-5-11(13)12-7-10(9-17)8-15-14(12)16/h3-9H,2H2,1H3 STZKMKMDWLBYSV-UHFFFAOYSA-N 261771 9-Ethyl-9H-pyrido[2,3-b]indole-3-carbaldehyde::US9708311, 22 Prostaglandin E2 receptor EP4 subtype Homo sapiens 65.7 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261771&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202363 376223609 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494340 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(=O)N1CC(O)C1 InChI=1S/C29H28N4O2/c1-2-32-25-6-4-3-5-22(25)23-13-19(9-11-26(23)32)28-30-24-14-20(29(35)31-16-21(34)17-31)10-12-27(24)33(28)15-18-7-8-18/h3-6,9-14,18,21,34H,2,7-8,15-17H2,1H3 UBXLTSASKGDACS-UHFFFAOYSA-N 261772 US9708311, 23::[1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazol-5-yl](3-hydroxyazetidin-1-yl)methanone Prostaglandin E2 receptor EP4 subtype Homo sapiens 143 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261772 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261772&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281992 376223610 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494341 CCOC(=O)c1ccc(NCC2CC2)c(N)c1 InChI=1S/C13H18N2O2/c1-2-17-13(16)10-5-6-12(11(14)7-10)15-8-9-3-4-9/h5-7,9,15H,2-4,8,14H2,1H3 GZDTXXXKAJSGJE-UHFFFAOYSA-N 261773 Ethyl 3-amino-4[(cyclopropylmethyl)amino]benzoate::US9708311, 24 Prostaglandin E2 receptor EP4 subtype Homo sapiens 338 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261773&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 61313447 376223611 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494342 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(=O)N(C)C InChI=1S/C28H28N4O/c1-4-31-24-8-6-5-7-21(24)22-15-19(11-13-25(22)31)27-29-23-16-20(28(33)30(2)3)12-14-26(23)32(27)17-18-9-10-18/h5-8,11-16,18H,4,9-10,17H2,1-3H3 SOPWZXFLPPMVOM-UHFFFAOYSA-N 261774 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-N,N-dimethyl-1H-benzimidazole-5-carboxamide::US9708311, 25 Prostaglandin E2 receptor EP4 subtype Homo sapiens 86.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261774&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282241 376223612 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494343 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(Br)ccc2n1CCOC InChI=1S/C24H22BrN3O/c1-3-27-21-7-5-4-6-18(21)19-14-16(8-10-22(19)27)24-26-20-15-17(25)9-11-23(20)28(24)12-13-29-2/h4-11,14-15H,3,12-13H2,1-2H3 PWWUTZYSKCFKHO-UHFFFAOYSA-N 261775 3-[5-Bromo-1-(2-methoxyethyl)-1H-benzimidazol-2-yl]-9-ethyl-9H-carbazole::US9708311, 26 Prostaglandin E2 receptor EP4 subtype Homo sapiens 176 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261775&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202503 376223613 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494344 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(=O)NCC(F)(F)F InChI=1S/C28H25F3N4O/c1-2-34-23-6-4-3-5-20(23)21-13-18(9-11-24(21)34)26-33-22-14-19(27(36)32-16-28(29,30)31)10-12-25(22)35(26)15-17-7-8-17/h3-6,9-14,17H,2,7-8,15-16H2,1H3,(H,32,36) WCTUADPVJPJBSL-UHFFFAOYSA-N 261776 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-N-(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide::US9708311, 27 Prostaglandin E2 receptor EP4 subtype Homo sapiens 117 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261776&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122420952 376223614 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494345 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(=O)N1CCNC(=O)C1 InChI=1S/C30H29N5O2/c1-2-34-25-6-4-3-5-22(25)23-15-20(9-11-26(23)34)29-32-24-16-21(30(37)33-14-13-31-28(36)18-33)10-12-27(24)35(29)17-19-7-8-19/h3-6,9-12,15-16,19H,2,7-8,13-14,17-18H2,1H3,(H,31,36) DCHRTLCGFHDIQD-UHFFFAOYSA-N 261777 4-{[1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazol-5-yl]carbonyl}-piperazin-2-one::US9708311, 28 Prostaglandin E2 receptor EP4 subtype Homo sapiens 122 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261777&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282245 376223615 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494346 CCOC(=O)c1ccc(NCCOC)c(N)c1 InChI=1S/C12H18N2O3/c1-3-17-12(15)9-4-5-11(10(13)8-9)14-6-7-16-2/h4-5,8,14H,3,6-7,13H2,1-2H3 PVZOGMQQRGQIIR-UHFFFAOYSA-N 261778 Ethyl 3-amino-4-[(2-methoxyethyl)amino]benzoate::US9708311, 29 Prostaglandin E2 receptor EP4 subtype Homo sapiens 219 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261778&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 56828465 376223616 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494347 CCOC(=O)c1ccc(NCCCOC)c(N)c1 InChI=1S/C13H20N2O3/c1-3-18-13(16)10-5-6-12(11(14)9-10)15-7-4-8-17-2/h5-6,9,15H,3-4,7-8,14H2,1-2H3 GMZZEDWJBPBODR-UHFFFAOYSA-N 261779 Ethyl 3-amino-4-[(3-methoxypropyl)amino]benzoate::US9708311, 30 Prostaglandin E2 receptor EP4 subtype Homo sapiens 30.1 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261779&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 56828496 376223617 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494348 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NCCOC InChI=1S/C28H30N4O3/c1-4-31-24-8-6-5-7-21(24)22-17-19(9-11-25(22)31)27-30-23-18-20(28(33)29-13-15-34-2)10-12-26(23)32(27)14-16-35-3/h5-12,17-18H,4,13-16H2,1-3H3,(H,29,33) OXOKKRVTIFTMHP-UHFFFAOYSA-N 261780 2-(9-Ethyl-9H-carbazol-3-yl)-N,1-bis(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 31 Prostaglandin E2 receptor EP4 subtype Homo sapiens 42.8 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261780&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282473 376223618 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494349 CCn1c2ccccc2c2cc(ccc12)-c1nc2c(F)c(Br)ccc2[nH]1 InChI=1S/C21H15BrFN3/c1-2-26-17-6-4-3-5-13(17)14-11-12(7-10-18(14)26)21-24-16-9-8-15(22)19(23)20(16)25-21/h3-11H,2H2,1H3,(H,24,25) DGBUQEUKIHWUJW-UHFFFAOYSA-N 261781 3-(5-Bromo-4-fluoro-1H-benzimidazol-2-yl)-9-ethyl-9H-carbazole::US9708311, 32 Prostaglandin E2 receptor EP4 subtype Homo sapiens 27.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261781&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202326 376223619 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494350 OC(=O)c1ccc2n(CC3CC3)c(nc2c1)-c1ccc2n(CC=C)c3ccccc3c2c1 InChI=1S/C27H23N3O2/c1-2-13-29-23-6-4-3-5-20(23)21-14-18(9-11-24(21)29)26-28-22-15-19(27(31)32)10-12-25(22)30(26)16-17-7-8-17/h2-6,9-12,14-15,17H,1,7-8,13,16H2,(H,31,32) JNBHAYIJLOISKK-UHFFFAOYSA-N 261782 2-(9-Allyl-9H-carbazol-3-yl)-1-(cyclopropylmethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 33 Prostaglandin E2 receptor EP4 subtype Homo sapiens 28.7 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261782&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282474 376223620 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494351 Cn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C25H21N3O2/c1-27-21-5-3-2-4-18(21)19-12-16(8-10-22(19)27)24-26-20-13-17(25(29)30)9-11-23(20)28(24)14-15-6-7-15/h2-5,8-13,15H,6-7,14H2,1H3,(H,29,30) QXAVQTCMAFPTHI-UHFFFAOYSA-N 261783 1-(Cyclopropylmethyl)-2-(9-methyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 34 Prostaglandin E2 receptor EP4 subtype Homo sapiens 39.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261783&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282476 376223621 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494352 CCn1c2ccc(Cl)cc2c2cc(C=O)ccc12 InChI=1S/C15H12ClNO/c1-2-17-14-5-3-10(9-18)7-12(14)13-8-11(16)4-6-15(13)17/h3-9H,2H2,1H3 NREGAMUYOIJUQQ-UHFFFAOYSA-N 261784 6-Chloro-9-ethyl-9H-carbazole-3-carbaldehyde and 8-chloro-9-ethyl-9H-carbazole-3-carbaldehyde::US9708311, 35 Prostaglandin E2 receptor EP4 subtype Homo sapiens 33.8 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261784&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 14222134 376223622 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494353 COCCn1c(nc2cc(ccc12)C(O)=O)-c1ccc2n(CC3CC3)c3ccccc3c2c1 InChI=1S/C27H25N3O3/c1-33-13-12-29-25-11-9-19(27(31)32)15-22(25)28-26(29)18-8-10-24-21(14-18)20-4-2-3-5-23(20)30(24)16-17-6-7-17/h2-5,8-11,14-15,17H,6-7,12-13,16H2,1H3,(H,31,32) BXTKOAWVQSCZBQ-UHFFFAOYSA-N 261785 2-[9-(Cyclopropylmethyl)-9H-carbazol-3-yl]-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 36 Prostaglandin E2 receptor EP4 subtype Homo sapiens 13.1 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261785&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282477 376223623 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494354 CCOC(=O)c1ccc2n(CCN3CCCC3)c(nc2c1)-c1ccc2n(CC)c3ccccc3c2c1 InChI=1S/C30H32N4O2/c1-3-33-26-10-6-5-9-23(26)24-19-21(11-13-27(24)33)29-31-25-20-22(30(35)36-4-2)12-14-28(25)34(29)18-17-32-15-7-8-16-32/h5-6,9-14,19-20H,3-4,7-8,15-18H2,1-2H3 JOUIHPVQCQZDQC-UHFFFAOYSA-N 261786 Ethyl 2-(9-ethyl-9H-carbazol-3-yl)-1-[2-(pyrrolidin-1-yl)ethyl]-1H-benzimidazole-5-carboxylate::US9708311, 37 Prostaglandin E2 receptor EP4 subtype Homo sapiens 3780 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261786&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282712 376223624 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494355 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN1CCCC1)C(O)=O InChI=1S/C28H28N4O2/c1-2-31-24-8-4-3-7-21(24)22-17-19(9-11-25(22)31)27-29-23-18-20(28(33)34)10-12-26(23)32(27)16-15-30-13-5-6-14-30/h3-4,7-12,17-18H,2,5-6,13-16H2,1H3,(H,33,34) FUGKHYQCNCZXOW-UHFFFAOYSA-N 261787 2-(9-Ethyl-9H-carbazol-3-yl)-1-[2-(pyrrolidin-1-yl)ethyl]-1H-benzimidazole-5-carboxylic acid::US9708311, 38 Prostaglandin E2 receptor EP4 subtype Homo sapiens 742 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261787&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282714 376223625 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494356 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)C(C)(C)C InChI=1S/C29H32N4O4S/c1-6-32-24-10-8-7-9-21(24)22-17-19(11-13-25(22)32)27-30-23-18-20(12-14-26(23)33(27)15-16-37-5)28(34)31-38(35,36)29(2,3)4/h7-14,17-18H,6,15-16H2,1-5H3,(H,31,34) QLSZBZGWACEMIL-UHFFFAOYSA-N 261788 N-(tert-Butylsulphonyl)-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 39 Prostaglandin E2 receptor EP4 subtype Homo sapiens 768 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261788&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282713 376223626 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494357 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)C1(C)CC1 InChI=1S/C29H30N4O4S/c1-4-32-24-8-6-5-7-21(24)22-17-19(9-11-25(22)32)27-30-23-18-20(10-12-26(23)33(27)15-16-37-3)28(34)31-38(35,36)29(2)13-14-29/h5-12,17-18H,4,13-16H2,1-3H3,(H,31,34) RBOLXHUPSNAVCW-UHFFFAOYSA-N 261789 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[(1-methylcyclopropyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 40 Prostaglandin E2 receptor EP4 subtype Homo sapiens 78.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261789&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282715 376223627 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494358 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NC InChI=1S/C26H26N4O2/c1-4-29-22-8-6-5-7-19(22)20-15-17(9-11-23(20)29)25-28-21-16-18(26(31)27-2)10-12-24(21)30(25)13-14-32-3/h5-12,15-16H,4,13-14H2,1-3H3,(H,27,31) DDPIUTCHLVTHOW-UHFFFAOYSA-N 261790 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-methyl-1H-benzimidazole-5-carboxamide::US9708311, 41 Prostaglandin E2 receptor EP4 subtype Homo sapiens 96.7 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261790&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202417 376223628 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494359 CCn1c2ccccc2c2nc(ccc12)-c1nc2cc(ccc2n1CCOC)C(O)=O InChI=1S/C24H22N4O3/c1-3-27-19-7-5-4-6-16(19)22-21(27)11-9-17(25-22)23-26-18-14-15(24(29)30)8-10-20(18)28(23)12-13-31-2/h4-11,14H,3,12-13H2,1-2H3,(H,29,30) KRBRKVFRAUTGNF-UHFFFAOYSA-N 261791 2-(5-Ethyl-5H-pyrido[3,2-b]indol-2-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 42 Prostaglandin E2 receptor EP4 subtype Homo sapiens 239 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261791&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284218 376223629 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494360 CCn1c2ccc(OC)cc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C27H25N3O3/c1-3-29-23-9-6-17(12-20(23)21-14-19(33-2)8-11-24(21)29)26-28-22-13-18(27(31)32)7-10-25(22)30(26)15-16-4-5-16/h6-14,16H,3-5,15H2,1-2H3,(H,31,32) QEAYAWUXJAJQPY-UHFFFAOYSA-N 261792 1-(Cyclopropylmethyl)-2-(9-ethyl-6-methoxy-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 43 Prostaglandin E2 receptor EP4 subtype Homo sapiens 54.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261792&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284217 376223630 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494361 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C#N InChI=1S/C25H22N4O/c1-3-28-22-7-5-4-6-19(22)20-15-18(9-11-23(20)28)25-27-21-14-17(16-26)8-10-24(21)29(25)12-13-30-2/h4-11,14-15H,3,12-13H2,1-2H3 LZUOJRMUZYPHQF-UHFFFAOYSA-N 261793 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carbonitrile::US9708311, 44 Prostaglandin E2 receptor EP4 subtype Homo sapiens 421 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261793&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284476 376223631 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494362 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)-c1nnn[nH]1 InChI=1S/C25H23N7O/c1-3-31-21-7-5-4-6-18(21)19-14-17(9-10-22(19)31)25-26-20-15-16(24-27-29-30-28-24)8-11-23(20)32(25)12-13-33-2/h4-11,14-15H,3,12-13H2,1-2H3,(H,27,28,29,30) WGKATYUSGJAUQC-UHFFFAOYSA-N 261794 9-Ethyl-3-[1-(2-methoxyethyl)-5-(1H-tetrazol-5-yl)-1H-benzimidazol-2-yl]-9H-carbazole::US9708311, 45 Prostaglandin E2 receptor EP4 subtype Homo sapiens 13.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261794&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284477 376223632 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494363 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)-c1noc(=O)[nH]1 InChI=1S/C26H23N5O3/c1-3-30-21-7-5-4-6-18(21)19-14-17(9-10-22(19)30)25-27-20-15-16(24-28-26(32)34-29-24)8-11-23(20)31(25)12-13-33-2/h4-11,14-15H,3,12-13H2,1-2H3,(H,28,29,32) LBFSKTSINNFQOD-UHFFFAOYSA-N 261795 3-[2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazol-5-yl]-1,2,4-oxadiazol-5(4H)-one::US9708311, 46 Prostaglandin E2 receptor EP4 subtype Homo sapiens 12.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261795&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 134823478 376223633 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494364 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1cccc(C)c1 InChI=1S/C32H30N4O4S/c1-4-35-28-11-6-5-10-25(28)26-19-22(12-14-29(26)35)31-33-27-20-23(13-15-30(27)36(31)16-17-40-3)32(37)34-41(38,39)24-9-7-8-21(2)18-24/h5-15,18-20H,4,16-17H2,1-3H3,(H,34,37) XRPFAFYKUKQUME-UHFFFAOYSA-N 261796 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[(3-methylphenyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 47 Prostaglandin E2 receptor EP4 subtype Homo sapiens 25.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261796&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284749 376223634 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494365 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccc(C)cc1 InChI=1S/C32H30N4O4S/c1-4-35-28-8-6-5-7-25(28)26-19-22(11-15-29(26)35)31-33-27-20-23(12-16-30(27)36(31)17-18-40-3)32(37)34-41(38,39)24-13-9-21(2)10-14-24/h5-16,19-20H,4,17-18H2,1-3H3,(H,34,37) JAMOMAYMYWAACL-UHFFFAOYSA-N 261797 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[(4-methylphenyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 48 Prostaglandin E2 receptor EP4 subtype Homo sapiens 99.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261797&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284748 376223635 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494366 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccc(Cl)cc1 InChI=1S/C31H27ClN4O4S/c1-3-35-27-7-5-4-6-24(27)25-18-20(8-14-28(25)35)30-33-26-19-21(9-15-29(26)36(30)16-17-40-2)31(37)34-41(38,39)23-12-10-22(32)11-13-23/h4-15,18-19H,3,16-17H2,1-2H3,(H,34,37) MYYIGNHJSOAAJI-UHFFFAOYSA-N 261798 N-[(4-Chlorophenyl)sulphonyl]-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 49 Prostaglandin E2 receptor EP4 subtype Homo sapiens 61.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261798&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76280918 376223636 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494367 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccccc1 InChI=1S/C31H28N4O4S/c1-3-34-27-12-8-7-11-24(27)25-19-21(13-15-28(25)34)30-32-26-20-22(14-16-29(26)35(30)17-18-39-2)31(36)33-40(37,38)23-9-5-4-6-10-23/h4-16,19-20H,3,17-18H2,1-2H3,(H,33,36) YXLVDGRAJMGDNC-UHFFFAOYSA-N 261799 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-(phenylsulphonyl)-1H-benzimidazole-5-carboxamide::US9708311, 50 Prostaglandin E2 receptor EP4 subtype Homo sapiens 33.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261799&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76280921 376223637 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494368 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccc2ccccc2c1 InChI=1S/C35H30N4O4S/c1-3-38-31-11-7-6-10-28(31)29-21-25(13-16-32(29)38)34-36-30-22-26(14-17-33(30)39(34)18-19-43-2)35(40)37-44(41,42)27-15-12-23-8-4-5-9-24(23)20-27/h4-17,20-22H,3,18-19H2,1-2H3,(H,37,40) MTSZVFXCGZFCJI-UHFFFAOYSA-N 261800 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-(2-naphthylsulphonyl)-1H-benzimidazole-5-carboxamide::US9708311, 51 Prostaglandin E2 receptor EP4 subtype Homo sapiens 95.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261800&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76280920 376223638 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494369 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccccc1OC InChI=1S/C32H30N4O5S/c1-4-35-26-10-6-5-9-23(26)24-19-21(13-15-27(24)35)31-33-25-20-22(14-16-28(25)36(31)17-18-40-2)32(37)34-42(38,39)30-12-8-7-11-29(30)41-3/h5-16,19-20H,4,17-18H2,1-3H3,(H,34,37) FGQHBDPGBISXMZ-UHFFFAOYSA-N 261801 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[(2-methoxyphenyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 52 Prostaglandin E2 receptor EP4 subtype Homo sapiens 35.9 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261801&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281183 376223639 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494370 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccccc1C InChI=1S/C32H30N4O4S/c1-4-35-27-11-7-6-10-24(27)25-19-22(13-15-28(25)35)31-33-26-20-23(14-16-29(26)36(31)17-18-40-3)32(37)34-41(38,39)30-12-8-5-9-21(30)2/h5-16,19-20H,4,17-18H2,1-3H3,(H,34,37) AFUBCOAWRGGMKL-UHFFFAOYSA-N 261802 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[(2-methylphenyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 53 Prostaglandin E2 receptor EP4 subtype Homo sapiens 35.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261802&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281729 376223640 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494371 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccccc1OC(F)(F)F InChI=1S/C32H27F3N4O5S/c1-3-38-25-9-5-4-8-22(25)23-18-20(12-14-26(23)38)30-36-24-19-21(13-15-27(24)39(30)16-17-43-2)31(40)37-45(41,42)29-11-7-6-10-28(29)44-32(33,34)35/h4-15,18-19H,3,16-17H2,1-2H3,(H,37,40) NZACIASZYUYCDF-UHFFFAOYSA-N 261803 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-{[2-(trifluoromethoxy)phenyl]-sulphonyl}-1H-benzimidazole-5-carboxamide::US9708311, 54 Prostaglandin E2 receptor EP4 subtype Homo sapiens 17.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261803&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281994 376223641 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494372 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1ccccc1 InChI=1S/C32H30N4O4S/c1-3-35-28-12-8-7-11-25(28)26-19-23(13-15-29(26)35)31-33-27-20-24(14-16-30(27)36(31)17-18-40-2)32(37)34-41(38,39)21-22-9-5-4-6-10-22/h4-16,19-20H,3,17-18,21H2,1-2H3,(H,34,37) AGLMDWQRPQFALK-UHFFFAOYSA-N 261804 N-(Benzylsulphonyl)-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 55 Prostaglandin E2 receptor EP4 subtype Homo sapiens 117 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261804&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281728 376223642 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494373 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)CCc1cccc(Cl)c1 InChI=1S/C33H31ClN4O4S/c1-3-37-29-10-5-4-9-26(29)27-20-23(11-13-30(27)37)32-35-28-21-24(12-14-31(28)38(32)16-17-42-2)33(39)36-43(40,41)18-15-22-7-6-8-25(34)19-22/h4-14,19-21H,3,15-18H2,1-2H3,(H,36,39) VPSSBSZCSDZMAM-UHFFFAOYSA-N 261805 N-{[2-(3-Chlorophenyl)ethyl]sulphonyl}-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 56 Prostaglandin E2 receptor EP4 subtype Homo sapiens 238 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261805&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281727 376223643 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494374 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)CCc1ccccc1C InChI=1S/C34H34N4O4S/c1-4-37-30-12-8-7-11-27(30)28-21-25(13-15-31(28)37)33-35-29-22-26(14-16-32(29)38(33)18-19-42-3)34(39)36-43(40,41)20-17-24-10-6-5-9-23(24)2/h5-16,21-22H,4,17-20H2,1-3H3,(H,36,39) DMQJDAYVVDQGDV-UHFFFAOYSA-N 261806 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-{[2-(2-methylphenyl)ethyl]sulphonyl}-1H-benzimidazole-5-carboxamide::US9708311, 57 Prostaglandin E2 receptor EP4 subtype Homo sapiens 239 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261806&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281458 376223644 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494375 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1ccc(F)cc1 InChI=1S/C32H29FN4O4S/c1-3-36-28-7-5-4-6-25(28)26-18-22(10-14-29(26)36)31-34-27-19-23(11-15-30(27)37(31)16-17-41-2)32(38)35-42(39,40)20-21-8-12-24(33)13-9-21/h4-15,18-19H,3,16-17,20H2,1-2H3,(H,35,38) LONOLPLOCZXXSE-UHFFFAOYSA-N 261807 2-(9-Ethyl-9H-carbazol-3-yl)-N-[(4-fluorobenzyl)sulphonyl]-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 58 Prostaglandin E2 receptor EP4 subtype Homo sapiens 174 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261807&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281726 376223645 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494376 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)CCOC InChI=1S/C28H30N4O5S/c1-4-31-24-8-6-5-7-21(24)22-17-19(9-11-25(22)31)27-29-23-18-20(10-12-26(23)32(27)13-14-36-2)28(33)30-38(34,35)16-15-37-3/h5-12,17-18H,4,13-16H2,1-3H3,(H,30,33) XNOIFDUKISVXHQ-UHFFFAOYSA-N 261808 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[(2-methoxyethyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 59 Prostaglandin E2 receptor EP4 subtype Homo sapiens 16.9 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261808&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281459 376223646 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494377 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1c(Cl)cccc1Cl InChI=1S/C32H28Cl2N4O4S/c1-3-37-28-10-5-4-7-22(28)23-17-20(11-13-29(23)37)31-35-27-18-21(12-14-30(27)38(31)15-16-42-2)32(39)36-43(40,41)19-24-25(33)8-6-9-26(24)34/h4-14,17-18H,3,15-16,19H2,1-2H3,(H,36,39) UHMQDZJBGAMDGW-UHFFFAOYSA-N 261809 N-[(2,6-Dichlorbenzyl)sulphonyl]-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 60 Prostaglandin E2 receptor EP4 subtype Homo sapiens 19.8 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261809&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281457 376223647 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494378 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)CCc1ccccc1Cl InChI=1S/C33H31ClN4O4S/c1-3-37-29-11-7-5-9-25(29)26-20-23(12-14-30(26)37)32-35-28-21-24(13-15-31(28)38(32)17-18-42-2)33(39)36-43(40,41)19-16-22-8-4-6-10-27(22)34/h4-15,20-21H,3,16-19H2,1-2H3,(H,36,39) GKWKIWZUKSUMGI-UHFFFAOYSA-N 261810 N-{[2-(2-Chlorophenyl)ethyl]sulphonyl}-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 61 Prostaglandin E2 receptor EP4 subtype Homo sapiens 167 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261810&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281456 376223648 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494379 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1ccc(cc1)C(F)(F)F InChI=1S/C33H29F3N4O4S/c1-3-39-28-7-5-4-6-25(28)26-18-22(10-14-29(26)39)31-37-27-19-23(11-15-30(27)40(31)16-17-44-2)32(41)38-45(42,43)20-21-8-12-24(13-9-21)33(34,35)36/h4-15,18-19H,3,16-17,20H2,1-2H3,(H,38,41) PLCOOUZYMSVRMK-UHFFFAOYSA-N 261811 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-{[4-(trifluoromethyl)benzyl]sulphonyl}-1H-benzimidazole-5-carboxamide::US9708311, 62 Prostaglandin E2 receptor EP4 subtype Homo sapiens 186 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261811&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284216 376223649 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494380 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)c1ccc(C)cn1 InChI=1S/C31H29N5O4S/c1-4-35-26-8-6-5-7-23(26)24-17-21(10-12-27(24)35)30-33-25-18-22(11-13-28(25)36(30)15-16-40-3)31(37)34-41(38,39)29-14-9-20(2)19-32-29/h5-14,17-19H,4,15-16H2,1-3H3,(H,34,37) OSYQANVSSWVJFR-UHFFFAOYSA-N 261812 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[(5-methylpyridin-2-yl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 63 Prostaglandin E2 receptor EP4 subtype Homo sapiens 117 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261812&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284474 376223650 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494381 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1ccc(Cl)cc1 InChI=1S/C32H29ClN4O4S/c1-3-36-28-7-5-4-6-25(28)26-18-22(10-14-29(26)36)31-34-27-19-23(11-15-30(27)37(31)16-17-41-2)32(38)35-42(39,40)20-21-8-12-24(33)13-9-21/h4-15,18-19H,3,16-17,20H2,1-2H3,(H,35,38) OGQRYBQYVNGTOV-UHFFFAOYSA-N 261813 N-[(4-Chlorobenzyl)sulphonyl]-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 64 Prostaglandin E2 receptor EP4 subtype Homo sapiens 138 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261813&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284475 376223651 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494382 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1ccccc1OC(F)(F)F InChI=1S/C33H29F3N4O5S/c1-3-39-27-10-6-5-9-24(27)25-18-21(12-14-28(25)39)31-37-26-19-22(13-15-29(26)40(31)16-17-44-2)32(41)38-46(42,43)20-23-8-4-7-11-30(23)45-33(34,35)36/h4-15,18-19H,3,16-17,20H2,1-2H3,(H,38,41) ZVJWAUNUIBTITP-UHFFFAOYSA-N 261814 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-{[2-(trifluoromethoxy)benzyl]-sulphonyl}-1H-benzimidazole-5-carboxamide::US9708311, 65 Prostaglandin E2 receptor EP4 subtype Homo sapiens 133 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261814&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284478 376223652 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494383 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)CC(C)(C)C InChI=1S/C30H34N4O4S/c1-6-33-25-10-8-7-9-22(25)23-17-20(11-13-26(23)33)28-31-24-18-21(12-14-27(24)34(28)15-16-38-5)29(35)32-39(36,37)19-30(2,3)4/h7-14,17-18H,6,15-16,19H2,1-5H3,(H,32,35) SDVYCYKOGINRBG-UHFFFAOYSA-N 261815 N-[(2,2-Dimethylpropyl)sulphonyl]-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 66 Prostaglandin E2 receptor EP4 subtype Homo sapiens 16.1 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261815&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284746 376223653 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494384 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1c(C)cccc1Cl InChI=1S/C33H31ClN4O4S/c1-4-37-29-11-6-5-9-24(29)25-18-22(12-14-30(25)37)32-35-28-19-23(13-15-31(28)38(32)16-17-42-3)33(39)36-43(40,41)20-26-21(2)8-7-10-27(26)34/h5-15,18-19H,4,16-17,20H2,1-3H3,(H,36,39) SAKSCZBFZXKWAH-UHFFFAOYSA-N 261816 N-[(2-Chloro-6-methylbenzyl)sulphonyl]-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxy-ethyl)-1H-benzimidazole-5-carboxamide::US9708311, 67 Prostaglandin E2 receptor EP4 subtype Homo sapiens 36.9 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261816&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284747 376223654 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494385 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)Cc1ncccc1C InChI=1S/C32H31N5O4S/c1-4-36-28-10-6-5-9-24(28)25-18-22(11-13-29(25)36)31-34-26-19-23(12-14-30(26)37(31)16-17-41-3)32(38)35-42(39,40)20-27-21(2)8-7-15-33-27/h5-15,18-19H,4,16-17,20H2,1-3H3,(H,35,38) ASAIEOHQNCLUAA-UHFFFAOYSA-N 261817 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-{[(3-methylpyridin-2-yl)methyl]-sulphonyl}-1H-benzimidazole-5-carboxamide::US9708311, 68 Prostaglandin E2 receptor EP4 subtype Homo sapiens 36.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261817&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76280919 376223655 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494386 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NS(=O)(=O)CCc1cccc(OC)c1 InChI=1S/C34H34N4O5S/c1-4-37-30-11-6-5-10-27(30)28-21-24(12-14-31(28)37)33-35-29-22-25(13-15-32(29)38(33)17-18-42-2)34(39)36-44(40,41)19-16-23-8-7-9-26(20-23)43-3/h5-15,20-22H,4,16-19H2,1-3H3,(H,36,39) YWJFEGNOIUMDEM-UHFFFAOYSA-N 261818 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-{[2-(3-methoxyphenyl)ethyl]-sulphonyl}-1H-benzimidazole-5-carboxamide::US9708311, 69 Prostaglandin E2 receptor EP4 subtype Homo sapiens 155 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261818&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281185 376223656 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494387 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN1CCOCC1)C(O)=O InChI=1S/C28H28N4O3/c1-2-31-24-6-4-3-5-21(24)22-17-19(7-9-25(22)31)27-29-23-18-20(28(33)34)8-10-26(23)32(27)12-11-30-13-15-35-16-14-30/h3-10,17-18H,2,11-16H2,1H3,(H,33,34) QRFDPXOPOVIWMQ-UHFFFAOYSA-N 261819 2-(9-Ethyl-9H-carbazol-3-yl)-1-[2-(morpholin-4-yl)ethyl]-1H-benzimidazole-5-carboxylic acid::US9708311, 70 Prostaglandin E2 receptor EP4 subtype Homo sapiens 2460 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261819&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281187 376223657 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494388 CCOC(=O)c1ccc2n(CCN(C)C)c(nc2c1)-c1ccc2n(CC)c3ccccc3c2c1 InChI=1S/C28H30N4O2/c1-5-31-24-10-8-7-9-21(24)22-17-19(11-13-25(22)31)27-29-23-18-20(28(33)34-6-2)12-14-26(23)32(27)16-15-30(3)4/h7-14,17-18H,5-6,15-16H2,1-4H3 METGUEUINHCSAY-UHFFFAOYSA-N 261820 Ethyl-1-[2-(dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylate::US9708311, 71 Prostaglandin E2 receptor EP4 subtype Homo sapiens 872 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261820&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281186 376223658 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494389 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN(C)C)C(O)=O InChI=1S/C26H26N4O2/c1-4-29-22-8-6-5-7-19(22)20-15-17(9-11-23(20)29)25-27-21-16-18(26(31)32)10-12-24(21)30(25)14-13-28(2)3/h5-12,15-16H,4,13-14H2,1-3H3,(H,31,32) DISXHZOECNRANJ-UHFFFAOYSA-N 261821 1-[2-(Dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 72 Prostaglandin E2 receptor EP4 subtype Homo sapiens 82.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261821&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76281184 376223659 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494390 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN(C)C)C(=O)NC InChI=1S/C27H29N5O/c1-5-31-23-9-7-6-8-20(23)21-16-18(10-12-24(21)31)26-29-22-17-19(27(33)28-2)11-13-25(22)32(26)15-14-30(3)4/h6-13,16-17H,5,14-15H2,1-4H3,(H,28,33) SAMLZVFZPJCTIM-UHFFFAOYSA-N 261822 1-[2-(Dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-N-methyl-1H-benzimidazole-5-carboxamide::US9708311, 73 Prostaglandin E2 receptor EP4 subtype Homo sapiens 382 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261822&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282960 376223660 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494391 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN(C)C)C(=O)NS(=O)(=O)C1CC1 InChI=1S/C29H31N5O3S/c1-4-33-25-8-6-5-7-22(25)23-17-19(9-13-26(23)33)28-30-24-18-20(29(35)31-38(36,37)21-11-12-21)10-14-27(24)34(28)16-15-32(2)3/h5-10,13-14,17-18,21H,4,11-12,15-16H2,1-3H3,(H,31,35) ZXHPLVGMTCDSBB-UHFFFAOYSA-N 261823 N-(Cyclopropylsulphonyl)-1-[2-(dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxamide::US9708311, 74 Prostaglandin E2 receptor EP4 subtype Homo sapiens 87.2 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261823&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282961 376223661 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494392 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN(C)C)C(=O)NS(=O)(=O)c1ccc(C)cc1 InChI=1S/C33H33N5O3S/c1-5-37-29-9-7-6-8-26(29)27-20-23(12-16-30(27)37)32-34-28-21-24(13-17-31(28)38(32)19-18-36(3)4)33(39)35-42(40,41)25-14-10-22(2)11-15-25/h6-17,20-21H,5,18-19H2,1-4H3,(H,35,39) QUUUVMYILCYILS-UHFFFAOYSA-N 261824 1-[2-(Dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-N-[(4-methylphenyl)sulphonyl]-1H-benzimidazole-5-carboxamide::US9708311, 75 Prostaglandin E2 receptor EP4 subtype Homo sapiens 21.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261824&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283204 376223662 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494393 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)N1CCCC1 InChI=1S/C29H30N4O2/c1-3-32-25-9-5-4-8-22(25)23-18-20(10-12-26(23)32)28-30-24-19-21(29(34)31-14-6-7-15-31)11-13-27(24)33(28)16-17-35-2/h4-5,8-13,18-19H,3,6-7,14-17H2,1-2H3 OZBQTUNVJXHZFV-UHFFFAOYSA-N 261825 US9708311, 76::[2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazol-5-yl](pyrrolidin-1-yl)-methanone Prostaglandin E2 receptor EP4 subtype Homo sapiens 41.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261825&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283203 376223663 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494394 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NCC(F)(F)F InChI=1S/C27H25F3N4O2/c1-3-33-22-7-5-4-6-19(22)20-14-17(8-10-23(20)33)25-32-21-15-18(26(35)31-16-27(28,29)30)9-11-24(21)34(25)12-13-36-2/h4-11,14-15H,3,12-13,16H2,1-2H3,(H,31,35) GHECYMCOVHFUSI-UHFFFAOYSA-N 261826 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-(2,2,2-trifluoroethyl)-1H-benzimidazole-5-carboxamide::US9708311, 77 Prostaglandin E2 receptor EP4 subtype Homo sapiens 49.2 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261826&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283206 376223664 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494395 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NCCN1CCOCC1 InChI=1S/C31H35N5O3/c1-3-35-27-7-5-4-6-24(27)25-20-22(8-10-28(25)35)30-33-26-21-23(9-11-29(26)36(30)16-17-38-2)31(37)32-12-13-34-14-18-39-19-15-34/h4-11,20-21H,3,12-19H2,1-2H3,(H,32,37) HNMBZLGCCJXNSZ-UHFFFAOYSA-N 261827 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[2-(morpholin-4-yl)ethyl]-1H-benzimidazole-5-carboxamide::US9708311, 78 Prostaglandin E2 receptor EP4 subtype Homo sapiens 74.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261827&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283207 376223665 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494396 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(=O)NCCN1CCOCC1 InChI=1S/C32H35N5O2/c1-2-36-28-6-4-3-5-25(28)26-19-23(9-11-29(26)36)31-34-27-20-24(10-12-30(27)37(31)21-22-7-8-22)32(38)33-13-14-35-15-17-39-18-16-35/h3-6,9-12,19-20,22H,2,7-8,13-18,21H2,1H3,(H,33,38) XGQZCVSKJRQHAF-UHFFFAOYSA-N 261828 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-N-[2-(morpholin-4-yl)ethyl]-1H-benzimidazole-5-carboxamide::US9708311, 79 Prostaglandin E2 receptor EP4 subtype Homo sapiens 106 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261828&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283439 376223666 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494397 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(=O)N1CCC1 InChI=1S/C29H28N4O/c1-2-32-25-7-4-3-6-22(25)23-16-20(10-12-26(23)32)28-30-24-17-21(29(34)31-14-5-15-31)11-13-27(24)33(28)18-19-8-9-19/h3-4,6-7,10-13,16-17,19H,2,5,8-9,14-15,18H2,1H3 GMQNKSLERQWIKN-UHFFFAOYSA-N 261829 Azetidin-1-yl[1-(cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazol-5-yl]-methanone::US9708311, 80 Prostaglandin E2 receptor EP4 subtype Homo sapiens 68.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261829&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283440 376223667 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494398 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)N1CCOCC1 InChI=1S/C29H30N4O3/c1-3-32-25-7-5-4-6-22(25)23-18-20(8-10-26(23)32)28-30-24-19-21(29(34)31-12-16-36-17-13-31)9-11-27(24)33(28)14-15-35-2/h4-11,18-19H,3,12-17H2,1-2H3 RCAOCLRNSATVGZ-UHFFFAOYSA-N 261830 US9708311, 81::[2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazol-5-yl](morpholin-4-yl)-methanone Prostaglandin E2 receptor EP4 subtype Homo sapiens 123 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261830&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283441 376223668 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494399 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(N)=O InChI=1S/C25H24N4O2/c1-3-28-21-7-5-4-6-18(21)19-14-17(9-10-22(19)28)25-27-20-15-16(24(26)30)8-11-23(20)29(25)12-13-31-2/h4-11,14-15H,3,12-13H2,1-2H3,(H2,26,30) IXYWOOOEFVLPLX-UHFFFAOYSA-N 261831 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 82 Prostaglandin E2 receptor EP4 subtype Homo sapiens 134 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261831&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283442 376223669 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494400 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)N(C)C InChI=1S/C27H28N4O2/c1-5-30-23-9-7-6-8-20(23)21-16-18(10-12-24(21)30)26-28-22-17-19(27(32)29(2)3)11-13-25(22)31(26)14-15-33-4/h6-13,16-17H,5,14-15H2,1-4H3 SCEHUWLJBULRSQ-UHFFFAOYSA-N 261832 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N,N-dimethyl-1H-benzimidazole-5-carboxamide::US9708311, 83 Prostaglandin E2 receptor EP4 subtype Homo sapiens 122 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261832&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283443 376223670 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494401 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)N(C)S(C)(=O)=O InChI=1S/C27H28N4O4S/c1-5-30-23-9-7-6-8-20(23)21-16-18(10-12-24(21)30)26-28-22-17-19(27(32)29(2)36(4,33)34)11-13-25(22)31(26)14-15-35-3/h6-13,16-17H,5,14-15H2,1-4H3 ABXWYZRPBQPAAG-UHFFFAOYSA-N 261833 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-methyl-N-(methylsulphonyl)-1H-benzimidazole-5-carboxamide::US9708311, 84 Prostaglandin E2 receptor EP4 subtype Homo sapiens 143 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261833&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283692 376223671 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494402 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC=C)C(=O)N(C)C InChI=1S/C27H26N4O/c1-5-15-31-25-14-12-19(27(32)29(3)4)17-22(25)28-26(31)18-11-13-24-21(16-18)20-9-7-8-10-23(20)30(24)6-2/h5,7-14,16-17H,1,6,15H2,2-4H3 BNIRHFUOOBNKLR-UHFFFAOYSA-N 261834 1-Allyl-2-(9-ethyl-9H-carbazol-3-yl)-N,N-dimethyl-1H-benzimidazole-5-carboxamide::US9708311, 85 Prostaglandin E2 receptor EP4 subtype Homo sapiens 1860 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261834&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283693 376223672 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494403 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NCCN(C)C InChI=1S/C29H33N5O2/c1-5-33-25-9-7-6-8-22(25)23-18-20(10-12-26(23)33)28-31-24-19-21(29(35)30-14-15-32(2)3)11-13-27(24)34(28)16-17-36-4/h6-13,18-19H,5,14-17H2,1-4H3,(H,30,35) NANLJBSYNNSPTF-UHFFFAOYSA-N 261835 N-[2-(Dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxamide::US9708311, 86 Prostaglandin E2 receptor EP4 subtype Homo sapiens 245 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261835&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283694 376223673 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494404 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(=O)NCCN1CCCC1 InChI=1S/C31H35N5O2/c1-3-35-27-9-5-4-8-24(27)25-20-22(10-12-28(25)35)30-33-26-21-23(11-13-29(26)36(30)18-19-38-2)31(37)32-14-17-34-15-6-7-16-34/h4-5,8-13,20-21H,3,6-7,14-19H2,1-2H3,(H,32,37) VHNKXWXRJPNBDG-UHFFFAOYSA-N 261836 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-N-[2-(pyrrolidin-1-yl)ethyl]-1H-benzimidazole-5-carboxamide::US9708311, 87 Prostaglandin E2 receptor EP4 subtype Homo sapiens 209 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261836&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283695 376223674 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494405 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC=C)C(=O)NC InChI=1S/C26H24N4O/c1-4-14-30-24-13-11-18(26(31)27-3)16-21(24)28-25(30)17-10-12-23-20(15-17)19-8-6-7-9-22(19)29(23)5-2/h4,6-13,15-16H,1,5,14H2,2-3H3,(H,27,31) KTYMOLFDOFFGJI-UHFFFAOYSA-N 261837 1-Allyl-2-(9-ethyl-9H-carbazol-3-yl)-N-methyl-1H-benzimidazole-5-carboxamide::US9708311, 88 Prostaglandin E2 receptor EP4 subtype Homo sapiens 2100 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261837&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283696 376223675 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494406 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC=C)C(N)=O InChI=1S/C25H22N4O/c1-3-13-29-23-12-9-16(24(26)30)15-20(23)27-25(29)17-10-11-22-19(14-17)18-7-5-6-8-21(18)28(22)4-2/h3,5-12,14-15H,1,4,13H2,2H3,(H2,26,30) BUTJHGAZBCBCOP-UHFFFAOYSA-N 261838 1-Allyl-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxamide::US9708311, 89 Prostaglandin E2 receptor EP4 subtype Homo sapiens 3640 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261838&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283946 376223676 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494407 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C)C(=O)NC InChI=1S/C24H22N4O/c1-4-28-20-8-6-5-7-17(20)18-13-15(9-11-21(18)28)23-26-19-14-16(24(29)25-2)10-12-22(19)27(23)3/h5-14H,4H2,1-3H3,(H,25,29) DKNWFLVKEXXROH-UHFFFAOYSA-N 261839 2-(9-Ethyl-9H-carbazol-3-yl)-N,1-dimethyl-1H-benzimidazole-5-carboxamide::US9708311, 90 Prostaglandin E2 receptor EP4 subtype Homo sapiens 2860 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261839&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122426092 376223677 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494408 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCO)C(O)=O InChI=1S/C24H21N3O3/c1-2-26-20-6-4-3-5-17(20)18-13-15(7-9-21(18)26)23-25-19-14-16(24(29)30)8-10-22(19)27(23)11-12-28/h3-10,13-14,28H,2,11-12H2,1H3,(H,29,30) ODXHWQWXZOXFPX-UHFFFAOYSA-N 261840 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-hydroxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 91 Prostaglandin E2 receptor EP4 subtype Homo sapiens 113 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261840&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283948 376223678 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494409 CCOC(=O)c1ccc2n(C(C)C)c(nc2c1)-c1ccc2n(CC)c3ccccc3c2c1 InChI=1S/C27H27N3O2/c1-5-29-23-10-8-7-9-20(23)21-15-18(11-13-24(21)29)26-28-22-16-19(27(31)32-6-2)12-14-25(22)30(26)17(3)4/h7-17H,5-6H2,1-4H3 PMMJUEFCMGVBQK-UHFFFAOYSA-N 261841 Ethyl 2-(9-ethyl-9H-carbazol-3-yl)-1-isopropyl-1H-benzimidazole-5-carboxylate::US9708311, 92 Prostaglandin E2 receptor EP4 subtype Homo sapiens 8000 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261841&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283949 376223679 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494410 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C(C)C)C(O)=O InChI=1S/C25H23N3O2/c1-4-27-21-8-6-5-7-18(21)19-13-16(9-11-22(19)27)24-26-20-14-17(25(29)30)10-12-23(20)28(24)15(2)3/h5-15H,4H2,1-3H3,(H,29,30) MHEQDBAVFQXCOV-UHFFFAOYSA-N 261843 2-(9-Ethyl-9H-carbazol-3-yl)-1-isopropyl-1H-benzimidazole-5-carboxylic acid::US9708311, 93 Prostaglandin E2 receptor EP4 subtype Homo sapiens 733 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261843&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283950 376223681 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494411 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C)C(O)=O InChI=1S/C23H19N3O2/c1-3-26-19-7-5-4-6-16(19)17-12-14(8-10-20(17)26)22-24-18-13-15(23(27)28)9-11-21(18)25(22)2/h4-13H,3H2,1-2H3,(H,27,28) VTAXFHATHOHPMA-UHFFFAOYSA-N 261844 2-(9-Ethyl-9H-carbazol-3-y1)-1-methyl-1 H-benzimidazole-5-carboxylic acid::US9708311, 94 Prostaglandin E2 receptor EP4 subtype Homo sapiens 195 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261844&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283951 376223682 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494412 CCn1c(nc2cc(ccc12)C(=O)OC)-c1ccc2n(CC)c3ccccc3c2c1 InChI=1S/C25H23N3O2/c1-4-27-21-9-7-6-8-18(21)19-14-16(10-12-22(19)27)24-26-20-15-17(25(29)30-3)11-13-23(20)28(24)5-2/h6-15H,4-5H2,1-3H3 LYNJDOGZYHQGFN-UHFFFAOYSA-N 261845 Methyl 1-ethyl-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylate::US9708311, 95 Prostaglandin E2 receptor EP4 subtype Homo sapiens 1030 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261845&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282716 376223683 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494413 COCCn1c(nc2cc(ccc12)C(O)=O)-c1ccc2n(CC=C)c3ccccc3c2c1 InChI=1S/C26H23N3O3/c1-3-12-28-22-7-5-4-6-19(22)20-15-17(8-10-23(20)28)25-27-21-16-18(26(30)31)9-11-24(21)29(25)13-14-32-2/h3-11,15-16H,1,12-14H2,2H3,(H,30,31) LGCHPYLRKINXIJ-UHFFFAOYSA-N 261846 2-(9-Allyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 96 Prostaglandin E2 receptor EP4 subtype Homo sapiens 16.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261846&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282963 376223684 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494414 CCOC(=O)c1ccc2n(CCOC)c(nc2c1)-c1ccc2n(CCOC)c3ccccc3c2c1 InChI=1S/C28H29N3O4/c1-4-35-28(32)20-10-12-26-23(18-20)29-27(31(26)14-16-34-3)19-9-11-25-22(17-19)21-7-5-6-8-24(21)30(25)13-15-33-2/h5-12,17-18H,4,13-16H2,1-3H3 AZGOQNLLQXSKFN-UHFFFAOYSA-N 261847 Ethyl 1-(2-methoxyethyl)-2-[9-(2-methoxyethyl)-9H-carbazol-3-yl]-1H-benzimidazole-5-carboxylate::US9708311, 97 Prostaglandin E2 receptor EP4 subtype Homo sapiens 412 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261847&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282962 376223685 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494415 COCCn1c(nc2cc(ccc12)C(O)=O)-c1ccc2n(CCOC)c3ccccc3c2c1 InChI=1S/C26H25N3O4/c1-32-13-11-28-22-6-4-3-5-19(22)20-15-17(7-9-23(20)28)25-27-21-16-18(26(30)31)8-10-24(21)29(25)12-14-33-2/h3-10,15-16H,11-14H2,1-2H3,(H,30,31) LVSATUIUXPKXFR-UHFFFAOYSA-N 261848 1-(2-Methoxyethyl)-2-[9-(2-methoxyethyl)-9H-carbazol-3-yl]-1H-benzimidazole-5-carboxylic acid::US9708311, 98 Prostaglandin E2 receptor EP4 subtype Homo sapiens 112 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261848&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76282964 376223686 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494416 CCOC(=O)c1ccc2n(CCCOC)c(nc2c1)-c1ccc2n(CC)c3ccccc3c2c1 InChI=1S/C28H29N3O3/c1-4-30-24-10-7-6-9-21(24)22-17-19(11-13-25(22)30)27-29-23-18-20(28(32)34-5-2)12-14-26(23)31(27)15-8-16-33-3/h6-7,9-14,17-18H,4-5,8,15-16H2,1-3H3 FLDOWCQVTOMQEU-UHFFFAOYSA-N 261849 Ethyl 2-(9-ethyl-9H-carbazol-3-yl)-1-(3-methoxypropyl)-1H-benzimidazole-5-carboxylate::US9708311, 99 Prostaglandin E2 receptor EP4 subtype Homo sapiens 1710 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261849&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76283205 376223687 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494417 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCCOC)C(O)=O InChI=1S/C26H25N3O3/c1-3-28-22-8-5-4-7-19(22)20-15-17(9-11-23(20)28)25-27-21-16-18(26(30)31)10-12-24(21)29(25)13-6-14-32-2/h4-5,7-12,15-16H,3,6,13-14H2,1-2H3,(H,30,31) CQUUTXQVFFFFMQ-UHFFFAOYSA-N 261850 2-(9-Ethyl-9H-carbazol-3-yl)-1-(3-methoxypropyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 100 Prostaglandin E2 receptor EP4 subtype Homo sapiens 158 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261850&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 76284215 376223688 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494418 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCCOC)C(C)(C)O InChI=1S/C28H31N3O2/c1-5-30-24-10-7-6-9-21(24)22-17-19(11-13-25(22)30)27-29-23-18-20(28(2,3)32)12-14-26(23)31(27)15-8-16-33-4/h6-7,9-14,17-18,32H,5,8,15-16H2,1-4H3 NSHPSDUKCPGZJK-UHFFFAOYSA-N 261851 2-[2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazol-5-yl]propan-2-ol::US9708311, 101 Prostaglandin E2 receptor EP4 subtype Homo sapiens 989 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261851&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122426093 376223689 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494419 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(C(O)=O)c(OC)cc2n1CC1CC1 InChI=1S/C27H25N3O3/c1-3-29-22-7-5-4-6-18(22)19-12-17(10-11-23(19)29)26-28-21-13-20(27(31)32)25(33-2)14-24(21)30(26)15-16-8-9-16/h4-7,10-14,16H,3,8-9,15H2,1-2H3,(H,31,32) OODXJBKGDCRQEA-UHFFFAOYSA-N 261852 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-6-methoxy-1H-benzimidazole-5-carboxylic acid::US9708311, 102 Prostaglandin E2 receptor EP4 subtype Homo sapiens 2830 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261852&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202380 376223690 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494420 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(C(O)=O)c(OC)cc2n1CCOC InChI=1S/C26H25N3O4/c1-4-28-21-8-6-5-7-17(21)18-13-16(9-10-22(18)28)25-27-20-14-19(26(30)31)24(33-3)15-23(20)29(25)11-12-32-2/h5-10,13-15H,4,11-12H2,1-3H3,(H,30,31) GIVBBEZUIKZZLH-UHFFFAOYSA-N 261853 2-(9-Ethyl-9H-carbazol-3-yl)-6-methoxy-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 103 Prostaglandin E2 receptor EP4 subtype Homo sapiens 3110 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261853&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202486 376223691 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494421 CCn1c2ccccc2c2cc(ccc12)-c1nc2c(OC)c(ccc2n1CC1CC1)C(O)=O InChI=1S/C27H25N3O3/c1-3-29-21-7-5-4-6-18(21)20-14-17(10-12-22(20)29)26-28-24-23(30(26)15-16-8-9-16)13-11-19(27(31)32)25(24)33-2/h4-7,10-14,16H,3,8-9,15H2,1-2H3,(H,31,32) PBDYTDWNLUIEIC-UHFFFAOYSA-N 261854 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-4-methoxy-1H-benzimidazole-5-carboxylic acid::US9708311, 104 Prostaglandin E2 receptor EP4 subtype Homo sapiens 64.4 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261854&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202863 376223692 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494422 CCn1c2ccccc2c2cc(ccc12)-c1nc2c(C)c(ccc2n1CCOC)C(O)=O InChI=1S/C26H25N3O3/c1-4-28-21-8-6-5-7-19(21)20-15-17(9-11-22(20)28)25-27-24-16(2)18(26(30)31)10-12-23(24)29(25)13-14-32-3/h5-12,15H,4,13-14H2,1-3H3,(H,30,31) UYIJGNNZVACBMR-UHFFFAOYSA-N 261855 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-4-methyl-1H-benzimidazole-5-carboxylic acid::US9708311, 105 Prostaglandin E2 receptor EP4 subtype Homo sapiens 64.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261855&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202404 376223693 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494423 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)-c1n[nH]c(=O)o1 InChI=1S/C26H23N5O3/c1-3-30-21-7-5-4-6-18(21)19-14-16(8-10-22(19)30)24-27-20-15-17(25-28-29-26(32)34-25)9-11-23(20)31(24)12-13-33-2/h4-11,14-15H,3,12-13H2,1-2H3,(H,29,32) WJXJMRKVJIYTMN-UHFFFAOYSA-N 261856 5-[2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazol-5-yl]-1,3,4-oxadiazol-2(3H)-one::US9708311, 106 Prostaglandin E2 receptor EP4 subtype Homo sapiens 43.7 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261856&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202554 376223694 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494424 CCn1c2ccccc2c2cc(cnc12)-c1nc2c(C)c(ccc2n1CC1CC1)C(O)=O InChI=1S/C26H24N4O2/c1-3-29-21-7-5-4-6-19(21)20-12-17(13-27-25(20)29)24-28-23-15(2)18(26(31)32)10-11-22(23)30(24)14-16-8-9-16/h4-7,10-13,16H,3,8-9,14H2,1-2H3,(H,31,32) HJJMKXDMBDVSML-UHFFFAOYSA-N 261857 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-pyrido[2,3-b]indol-3-yl)-4-methyl-1H-benzimidazole-5-carboxylic acid::US9708311, 107 Prostaglandin E2 receptor EP4 subtype Homo sapiens 433 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261857&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122420951 376223695 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494425 CCn1c2ccc(cc2c2ccncc12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C25H22N4O2/c1-2-28-21-7-5-16(11-19(21)18-9-10-26-13-23(18)28)24-27-20-12-17(25(30)31)6-8-22(20)29(24)14-15-3-4-15/h5-13,15H,2-4,14H2,1H3,(H,30,31) KHSJFGUPDOZGHZ-UHFFFAOYSA-N 261858 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-beta-carbolin-6-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 108 Prostaglandin E2 receptor EP4 subtype Homo sapiens 119 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261858&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202484 376223696 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494426 CCn1c2ccncc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C25H22N4O2/c1-2-28-21-7-5-16(11-18(21)19-13-26-10-9-22(19)28)24-27-20-12-17(25(30)31)6-8-23(20)29(24)14-15-3-4-15/h5-13,15H,2-4,14H2,1H3,(H,30,31) UACXWYYXMSEMKI-UHFFFAOYSA-N 261859 1-(Cyclopropylmethyl)-2-(5-ethyl-5H-pyrido[4,3-b]indol-8-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 109 Prostaglandin E2 receptor EP4 subtype Homo sapiens 178 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261859&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202585 376223697 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494427 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(C(O)=O)c(C)cc2n1CC1CC1 InChI=1S/C27H25N3O2/c1-3-29-23-7-5-4-6-19(23)21-13-18(10-11-24(21)29)26-28-22-14-20(27(31)32)16(2)12-25(22)30(26)15-17-8-9-17/h4-7,10-14,17H,3,8-9,15H2,1-2H3,(H,31,32) BWQPVQKMQJNGJD-UHFFFAOYSA-N 261860 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-6-methyl-1H-benzimidazole-5-carboxylic acid::US9708311, 110 Prostaglandin E2 receptor EP4 subtype Homo sapiens 1180 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261860&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202536 376223698 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494428 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(C(O)=O)c(C)cc2n1CCOC InChI=1S/C26H25N3O3/c1-4-28-22-8-6-5-7-18(22)20-14-17(9-10-23(20)28)25-27-21-15-19(26(30)31)16(2)13-24(21)29(25)11-12-32-3/h5-10,13-15H,4,11-12H2,1-3H3,(H,30,31) OHCPIAVGSMNZKZ-UHFFFAOYSA-N 261861 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-6-methyl-1H-benzimidazole-5-carboxylic acid::US9708311, 111 Prostaglandin E2 receptor EP4 subtype Homo sapiens 612 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261861&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202748 376223699 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494429 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(C(O)=O)c(F)cc2n1CC1CC1 InChI=1S/C26H22FN3O2/c1-2-29-22-6-4-3-5-17(22)18-11-16(9-10-23(18)29)25-28-21-12-19(26(31)32)20(27)13-24(21)30(25)14-15-7-8-15/h3-6,9-13,15H,2,7-8,14H2,1H3,(H,31,32) JYMMCQLLFAFGHN-UHFFFAOYSA-N 261862 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-6-fluoro-1H-benzimidazole-5-carboxylic acid::US9708311, 112 Prostaglandin E2 receptor EP4 subtype Homo sapiens 34.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261862&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202677 376223700 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494430 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(C(O)=O)c(F)cc2n1CCOC InChI=1S/C25H22FN3O3/c1-3-28-21-7-5-4-6-16(21)17-12-15(8-9-22(17)28)24-27-20-13-18(25(30)31)19(26)14-23(20)29(24)10-11-32-2/h4-9,12-14H,3,10-11H2,1-2H3,(H,30,31) GGLRAOVFLKWYNU-UHFFFAOYSA-N 261863 2-(9-Ethyl-9H-carbazol-3-yl)-6-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 113 Prostaglandin E2 receptor EP4 subtype Homo sapiens 59.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261863&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202545 376223701 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494431 CCn1c2ccccc2c2cc(ccc12)-c1nc2c(F)c(ccc2n1CCOC)C(O)=O InChI=1S/C25H22FN3O3/c1-3-28-19-7-5-4-6-16(19)18-14-15(8-10-20(18)28)24-27-23-21(29(24)12-13-32-2)11-9-17(22(23)26)25(30)31/h4-11,14H,3,12-13H2,1-2H3,(H,30,31) DUFQDZCZLLVKQR-UHFFFAOYSA-N 261864 2-(9-Ethyl-9H-carbazol-3-yl)-4-fluoro-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 114 Prostaglandin E2 receptor EP4 subtype Homo sapiens 6.42 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261864&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202587 376223702 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494432 CCn1c2ccccc2c2cc(ccc12)-c1nc2c(F)c(ccc2n1CC1CC1)C(O)=O InChI=1S/C26H22FN3O2/c1-2-29-20-6-4-3-5-17(20)19-13-16(9-11-21(19)29)25-28-24-22(30(25)14-15-7-8-15)12-10-18(23(24)27)26(31)32/h3-6,9-13,15H,2,7-8,14H2,1H3,(H,31,32) PZSWYLZSYHZFSY-UHFFFAOYSA-N 261865 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-carbazol-3-yl)-4-fluoro-1H-benzimidazole-5-carboxylic acid::US9708311, 115 Prostaglandin E2 receptor EP4 subtype Homo sapiens 11.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261865&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202419 376223703 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494433 CCn1c2ccc(cc2c2cccnc12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C25H22N4O2/c1-2-28-21-9-7-16(12-19(21)18-4-3-11-26-24(18)28)23-27-20-13-17(25(30)31)8-10-22(20)29(23)14-15-5-6-15/h3-4,7-13,15H,2,5-6,14H2,1H3,(H,30,31) OQQWRHPJHVJCQL-UHFFFAOYSA-N 261866 1-(Cyclopropylmethyl)-2-(9-ethyl-9H-pyrido[2,3-b]indol-6-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 116 Prostaglandin E2 receptor EP4 subtype Homo sapiens 22.2 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261866&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202628 376223704 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494434 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCC1CC1)C(O)=O InChI=1S/C27H25N3O2/c1-2-29-23-6-4-3-5-20(23)21-15-18(9-11-24(21)29)26-28-22-16-19(27(31)32)10-12-25(22)30(26)14-13-17-7-8-17/h3-6,9-12,15-17H,2,7-8,13-14H2,1H3,(H,31,32) WFHPTQLOIAKZQP-UHFFFAOYSA-N 261867 1-(2-Cyclopropylethyl)-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 117 Prostaglandin E2 receptor EP4 subtype Homo sapiens 22.1 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261867&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202708 376223705 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494435 CCCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)C(O)=O InChI=1S/C26H25N3O3/c1-3-12-28-22-7-5-4-6-19(22)20-15-17(8-10-23(20)28)25-27-21-16-18(26(30)31)9-11-24(21)29(25)13-14-32-2/h4-11,15-16H,3,12-14H2,1-2H3,(H,30,31) PEWXSYIXHHFVSI-UHFFFAOYSA-N 261868 1-(2-Methoxyethyl)-2-(9-propyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 118 Prostaglandin E2 receptor EP4 subtype Homo sapiens 36.2 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261868&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202472 376223706 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494436 COCCn1c(nc2cc(ccc12)C(O)=O)-c1ccc2n(CC#C)c3ccccc3c2c1 InChI=1S/C26H21N3O3/c1-3-12-28-22-7-5-4-6-19(22)20-15-17(8-10-23(20)28)25-27-21-16-18(26(30)31)9-11-24(21)29(25)13-14-32-2/h1,4-11,15-16H,12-14H2,2H3,(H,30,31) PTPUMBAQYIXOIX-UHFFFAOYSA-N 261869 1-(2-Methoxyethyl)-2-[9-(prop-2-yn-1-yl)-9H-carbazol-3-yl]-1H-benzimidazole-5-carboxylic acid::US9708311, 119 Prostaglandin E2 receptor EP4 subtype Homo sapiens 43.7 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261869&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122420961 376223707 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494437 CCCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C27H25N3O2/c1-2-13-29-23-6-4-3-5-20(23)21-14-18(9-11-24(21)29)26-28-22-15-19(27(31)32)10-12-25(22)30(26)16-17-7-8-17/h3-6,9-12,14-15,17H,2,7-8,13,16H2,1H3,(H,31,32) CQLAEMXFJFUNRC-UHFFFAOYSA-N 261871 1-(Cyclopropylmethyl)-2-(9-propyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 120 Prostaglandin E2 receptor EP4 subtype Homo sapiens 63.0 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261871&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202705 376223709 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494438 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CC1(C)C)C(O)=O InChI=1S/C28H27N3O2/c1-4-30-23-8-6-5-7-20(23)21-13-17(9-11-24(21)30)26-29-22-14-18(27(32)33)10-12-25(22)31(26)16-19-15-28(19,2)3/h5-14,19H,4,15-16H2,1-3H3,(H,32,33) ANNBMWKEZQOIED-UHFFFAOYSA-N 261872 1-[(2,2-Dimethylcyclopropyl)methyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 121 Prostaglandin E2 receptor EP4 subtype Homo sapiens 100.0 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261872&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122420943 376223710 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494439 CCOC(=O)c1ccc2n(CC3COC3)c(nc2c1)-c1ccc2n(CC)c3ccccc3c2c1 InChI=1S/C28H27N3O3/c1-3-30-24-8-6-5-7-21(24)22-13-19(9-11-25(22)30)27-29-23-14-20(28(32)34-4-2)10-12-26(23)31(27)15-18-16-33-17-18/h5-14,18H,3-4,15-17H2,1-2H3 GNQHCGMAMYAYOJ-UHFFFAOYSA-N 261873 Ethyl 2-(9-ethyl-9H-carbazol-3-yl)-1-(oxetan-3-ylmethyl)-1H-benzimidazole-5-carboxylate::US9708311, 122 Prostaglandin E2 receptor EP4 subtype Homo sapiens 464 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261873&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122420941 376223711 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494440 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1COC1)C(O)=O InChI=1S/C26H23N3O3/c1-2-28-22-6-4-3-5-19(22)20-11-17(7-9-23(20)28)25-27-21-12-18(26(30)31)8-10-24(21)29(25)13-16-14-32-15-16/h3-12,16H,2,13-15H2,1H3,(H,30,31) JDOSJWHLPMCIKO-UHFFFAOYSA-N 261874 2-(9-Ethyl-9H-carbazol-3-yl)-1-(oxetan-3-ylmethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 123 Prostaglandin E2 receptor EP4 subtype Homo sapiens 51.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261874&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202569 376223712 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494441 COCCn1c(nc2cc(ccc12)C(O)=O)-c1ccc2n(CC3CCC3)c3ccccc3c2c1 InChI=1S/C28H27N3O3/c1-34-14-13-30-26-12-10-20(28(32)33)16-23(26)29-27(30)19-9-11-25-22(15-19)21-7-2-3-8-24(21)31(25)17-18-5-4-6-18/h2-3,7-12,15-16,18H,4-6,13-14,17H2,1H3,(H,32,33) WQVQCZLVBSEMRD-UHFFFAOYSA-N 261875 2-[9-(Cyclobutylmethyl)-9H-carbazol-3-yl]-1-(2-methoxyethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 124 Prostaglandin E2 receptor EP4 subtype Homo sapiens 94.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261875&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202306 376223713 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494442 OC(=O)c1ccc2n(CC3CC3)c(nc2c1)-c1ccc2n(CC3CCC3)c3ccccc3c2c1 InChI=1S/C29H27N3O2/c33-29(34)21-11-13-27-24(15-21)30-28(32(27)17-19-8-9-19)20-10-12-26-23(14-20)22-6-1-2-7-25(22)31(26)16-18-4-3-5-18/h1-2,6-7,10-15,18-19H,3-5,8-9,16-17H2,(H,33,34) URXPFHBOWBEBKM-UHFFFAOYSA-N 261876 2-[9-(Cyclobutylmethyl)-9H-carbazol-3-yl]-1-(cyclopropylmethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 125 Prostaglandin E2 receptor EP4 subtype Homo sapiens 257 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261876&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202707 376223714 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494443 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCN(C)C)-c1n[nH]c(=O)o1 InChI=1S/C27H26N6O2/c1-4-32-22-8-6-5-7-19(22)20-15-17(9-11-23(20)32)25-28-21-16-18(26-29-30-27(34)35-26)10-12-24(21)33(25)14-13-31(2)3/h5-12,15-16H,4,13-14H2,1-3H3,(H,30,34) SVSQSCFLMGQUDL-UHFFFAOYSA-N 261877 5-{1-[2-(Dimethylamino)ethyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazol-5-yl}-1,3,4-oxadiazol-2(3H)-one::US9708311, 126 Prostaglandin E2 receptor EP4 subtype Homo sapiens 118 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261877&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202572 376223715 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494444 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC)S(N)(=O)=O InChI=1S/C24H24N4O3S/c1-3-27-21-7-5-4-6-18(21)19-14-16(8-10-22(19)27)24-26-20-15-17(32(25,29)30)9-11-23(20)28(24)12-13-31-2/h4-11,14-15H,3,12-13H2,1-2H3,(H2,25,29,30) FJNWJXAACMXEIE-UHFFFAOYSA-N 261878 2-(9-Ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-1H-benzimidazole-5-sulphonamide::US9708311, 127 Prostaglandin E2 receptor EP4 subtype Homo sapiens 305 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261878&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202598 376223716 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494445 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C)-n1ccnn1 InChI=1S/C24H20N6/c1-3-29-21-7-5-4-6-18(21)19-14-16(8-10-22(19)29)24-26-20-15-17(30-13-12-25-27-30)9-11-23(20)28(24)2/h4-15H,3H2,1-2H3 ZSEFHZBAIXQASL-UHFFFAOYSA-N 261879 9-Ethyl-3-[1-methyl-5-(1H-1,2,3-triazol-1-yl)-1H-benzimidazole-2-yl]-9H-carbazole::US9708311, 128 Prostaglandin E2 receptor EP4 subtype Homo sapiens 111 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261879&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122420944 376223717 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494446 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C)S(=O)(=O)NC InChI=1S/C23H22N4O2S/c1-4-27-20-8-6-5-7-17(20)18-13-15(9-11-21(18)27)23-25-19-14-16(30(28,29)24-2)10-12-22(19)26(23)3/h5-14,24H,4H2,1-3H3 PKQSHXIJTDRJIO-UHFFFAOYSA-N 261880 2-(9-Ethyl-9H-carbazol-3-yl)-N,1-dimethyl-1H-benzimidazole-5-sulphonamide::US9708311, 129 Prostaglandin E2 receptor EP4 subtype Homo sapiens 944 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261880&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122425652 376223718 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494447 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCOC(F)(F)F)C(O)=O InChI=1S/C25H20F3N3O3/c1-2-30-20-6-4-3-5-17(20)18-13-15(7-9-21(18)30)23-29-19-14-16(24(32)33)8-10-22(19)31(23)11-12-34-25(26,27)28/h3-10,13-14H,2,11-12H2,1H3,(H,32,33) VTALIBBCVSUPQG-UHFFFAOYSA-N 261881 2-(9-Ethyl-9H-carbazol-3-yl)-1-[2-(trifluoromethoxy)ethyl]-1H-benzimidazole-5-carboxylic acid::US9708311, 130 Prostaglandin E2 receptor EP4 subtype Homo sapiens 14.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261881&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202670 376223719 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494448 CCn1c2ccccc2c2cc(nc(C)c12)-c1nc2cc(ccc2n1CC1CC1)C(O)=O InChI=1S/C26H24N4O2/c1-3-29-22-7-5-4-6-18(22)19-13-21(27-15(2)24(19)29)25-28-20-12-17(26(31)32)10-11-23(20)30(25)14-16-8-9-16/h4-7,10-13,16H,3,8-9,14H2,1-2H3,(H,31,32) NCSKSDRTTUYJAG-UHFFFAOYSA-N 261882 1-(Cyclopropylmethyl)-2-(9-ethyl-1-methyl-9H-beta-carbolin-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 131 Prostaglandin E2 receptor EP4 subtype Homo sapiens 480 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261882&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202695 376223720 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494449 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CCO1)C(O)=O InChI=1S/C26H23N3O3/c1-2-28-22-6-4-3-5-19(22)20-13-16(7-9-23(20)28)25-27-21-14-17(26(30)31)8-10-24(21)29(25)15-18-11-12-32-18/h3-10,13-14,18H,2,11-12,15H2,1H3,(H,30,31) QIEOWOHGBXQKMF-UHFFFAOYSA-N 261883 2-(9-Ethyl-9H-carbazol-3-yl)-1-(oxetan-2-ylmethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 132 Prostaglandin E2 receptor EP4 subtype Homo sapiens 24.5 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261883&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202594 376223721 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494450 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC1CCCO1)C(O)=O InChI=1S/C27H25N3O3/c1-2-29-23-8-4-3-7-20(23)21-14-17(9-11-24(21)29)26-28-22-15-18(27(31)32)10-12-25(22)30(26)16-19-6-5-13-33-19/h3-4,7-12,14-15,19H,2,5-6,13,16H2,1H3,(H,31,32) XNIZGEFJXNDHLS-UHFFFAOYSA-N 261884 2-(9-Ethyl-9H-carbazol-3-yl)-1-(tetrahydrofuran-2-ylmethyl)-1H-benzimidazole-5-carboxylic acid::US9708311, 133 Prostaglandin E2 receptor EP4 subtype Homo sapiens 7.00 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261884&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202290 376223722 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494451 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C[C@@H](O)COC)C(O)=O InChI=1S/C26H25N3O4/c1-3-28-22-7-5-4-6-19(22)20-12-16(8-10-23(20)28)25-27-21-13-17(26(31)32)9-11-24(21)29(25)14-18(30)15-33-2/h4-13,18,30H,3,14-15H2,1-2H3,(H,31,32)/t18-/m1/s1 FYZHEYINKISOSE-GOSISDBHSA-N 261885 2-(9-Ethyl-9H-carbazol-3-yl)-1-[(2R)-2-hydroxy-3-methoxypropyl]-1H-benzimidazole-5-carboxylic acid::US9708311, 134 Prostaglandin E2 receptor EP4 subtype Homo sapiens 136 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261885&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202350 376223723 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494452 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C[C@H](O)COC)C(O)=O InChI=1S/C26H25N3O4/c1-3-28-22-7-5-4-6-19(22)20-12-16(8-10-23(20)28)25-27-21-13-17(26(31)32)9-11-24(21)29(25)14-18(30)15-33-2/h4-13,18,30H,3,14-15H2,1-2H3,(H,31,32)/t18-/m0/s1 FYZHEYINKISOSE-SFHVURJKSA-N 261886 2-(9-Ethyl-9H-carbazol-3-yl)-1-[(2S)-2-hydroxy-3-methoxypropyl]-1H-benzimidazole-5-carboxylic acid::US9708311, 135 Prostaglandin E2 receptor EP4 subtype Homo sapiens 340 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261886&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202559 376223724 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494453 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CCS(C)(=O)=O)C(O)=O InChI=1S/C25H23N3O4S/c1-3-27-21-7-5-4-6-18(21)19-14-16(8-10-22(19)27)24-26-20-15-17(25(29)30)9-11-23(20)28(24)12-13-33(2,31)32/h4-11,14-15H,3,12-13H2,1-2H3,(H,29,30) UNRDYSLYFZTCQW-UHFFFAOYSA-N 261887 2-(9-Ethyl-9H-carbazol-3-yl)-1-[2-(methylsulphonyl)ethyl]-1H-benzimidazole-5-carboxylic acid::US9708311, 136 Prostaglandin E2 receptor EP4 subtype Homo sapiens 325 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261887&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202771 376223725 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494454 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC(O)C1CC1)C(O)=O InChI=1S/C27H25N3O3/c1-2-29-22-6-4-3-5-19(22)20-13-17(9-11-23(20)29)26-28-21-14-18(27(32)33)10-12-24(21)30(26)15-25(31)16-7-8-16/h3-6,9-14,16,25,31H,2,7-8,15H2,1H3,(H,32,33) RYUKCSMZZCGEIR-UHFFFAOYSA-N 261888 1-(2-Cyclopropyl-2-hydroxyethyl)-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 137 Prostaglandin E2 receptor EP4 subtype Homo sapiens 18.6 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261888&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202689 376223726 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494455 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1CC(O)CO)C(O)=O InChI=1S/C25H23N3O4/c1-2-27-21-6-4-3-5-18(21)19-11-15(7-9-22(19)27)24-26-20-12-16(25(31)32)8-10-23(20)28(24)13-17(30)14-29/h3-12,17,29-30H,2,13-14H2,1H3,(H,31,32) ACULBGOBNAAIPK-UHFFFAOYSA-N 261889 1-[(2S)-2,3-Dihydroxypropyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 138 Prostaglandin E2 receptor EP4 subtype Homo sapiens 567 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261889&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122426240 376223727 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494456 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C[C@@H]1COCCO1)C(O)=O InChI=1S/C27H25N3O4/c1-2-29-23-6-4-3-5-20(23)21-13-17(7-9-24(21)29)26-28-22-14-18(27(31)32)8-10-25(22)30(26)15-19-16-33-11-12-34-19/h3-10,13-14,19H,2,11-12,15-16H2,1H3,(H,31,32)/t19-/m1/s1 JXIMJWLDISCDNL-LJQANCHMSA-N 261890 1-[(2R)-1,4-Dioxan-2-ylmethyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-carboxylic acid::US9708311, 139 Prostaglandin E2 receptor EP4 subtype Homo sapiens 252 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261890&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122420954 376223728 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494457 CCn1c2ccccc2c2cc(ccc12)-c1nc2cc(ccc2n1C[C@H]1COCCO1)C(O)=O InChI=1S/C27H25N3O4/c1-2-29-23-6-4-3-5-20(23)21-13-17(7-9-24(21)29)26-28-22-14-18(27(31)32)8-10-25(22)30(26)15-19-16-33-11-12-34-19/h3-10,13-14,19H,2,11-12,15-16H2,1H3,(H,31,32)/t19-/m0/s1 JXIMJWLDISCDNL-IBGZPJMESA-N 261891 1-[(2S)-1,4-Dioxan-2-ylmethyl]-2-(9-ethyl-9H-carbazol-3-yl)-1H-benzimidazole-5-5 carboxylic acid::US9708311, 140 Prostaglandin E2 receptor EP4 subtype Homo sapiens 176 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261891&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 122426242 376223729 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494458 CCn1c2ccc(C)cc2c2cc(ccc12)-c1nc2c(C)c(ccc2n1CCOC)C(O)=O InChI=1S/C27H27N3O3/c1-5-29-22-9-6-16(2)14-20(22)21-15-18(7-10-23(21)29)26-28-25-17(3)19(27(31)32)8-11-24(25)30(26)12-13-33-4/h6-11,14-15H,5,12-13H2,1-4H3,(H,31,32) FHXIZAPGGULPIK-UHFFFAOYSA-N 261892 2-(9-Ethyl-6-methyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-4-methyl-1H-benzimidazole-5-carboxylic acid::US9708311, 141 Prostaglandin E2 receptor EP4 subtype Homo sapiens 15.3 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261892&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202558 376223730 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494459 CCn1c2ccc(Cl)cc2c2cc(ccc12)-c1nc2c(C)c(ccc2n1CCOC)C(O)=O InChI=1S/C26H24ClN3O3/c1-4-29-21-8-5-16(13-19(21)20-14-17(27)6-9-22(20)29)25-28-24-15(2)18(26(31)32)7-10-23(24)30(25)11-12-33-3/h5-10,13-14H,4,11-12H2,1-3H3,(H,31,32) PNGKCFGAJWAWGO-UHFFFAOYSA-N 261893 2-(6-Chloro-9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-4-methyl-1H-benzimidazole-5-carboxylic acid::US9708311, 142 Prostaglandin E2 receptor EP4 subtype Homo sapiens 4.16 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261893&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202660 376223731 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87 494460 CCn1c2ccc(cc2c2cccc(Cl)c12)-c1nc2c(C)c(ccc2n1CCOC)C(O)=O InChI=1S/C26H24ClN3O3/c1-4-29-21-10-8-16(14-19(21)18-6-5-7-20(27)24(18)29)25-28-23-15(2)17(26(31)32)9-11-22(23)30(25)12-13-33-3/h5-11,14H,4,12-13H2,1-3H3,(H,31,32) BXQVRCKNIKOYII-UHFFFAOYSA-N 261894 2-(8-Chloro-9-ethyl-9H-carbazol-3-yl)-1-(2-methoxyethyl)-4-methyl-1H-benzimidazole-5-carboxylic acid::US9708311, 143 Prostaglandin E2 receptor EP4 subtype Homo sapiens 5.19 25.00 C US Patent 10.7270/Q23F4RPM aid1795208 US9708311 Peters, O; Brauer, N; Blume, T; Ter Laak, A; Zorn, L; Nagel, J; Kaulfuss, S; Langer, G; Kuhnke, J 7/18/2017 10/31/2018 Bayer Pharma Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=261894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=6097&target=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=261894&enzyme=Prostaglandin+E2+receptor+EP4+subtype&column=ki&startPg=0&Increment=50&submit=Search 90202434 376223732 1 MSTPGVNSSASLSPDRLNSPVTIPAVMFIFGVVGNLVAIVVLCKSRKEQKETTFYTLVCGLAVTDLLGTLLVSPVTIATYMKGQWPGGQPLCEYSTFILLFFSLSGLSIICAMSVERYLAINHAYFYSHYVDKRLAGLTLFAVYASNVLFCALPNMGLGSSRLQYPDTWCFIDWTTNVTAHAAYSYMYAGFSSFLILATVLCNVLVCGALLRMHRQFMRRTSLGTEQHHAAAAASVASRGHPAASPALPRLSDFRRRRSFRRIAGAEIQMVILLIATSLVVLICSIPLVVRVFVNQLYQPSLEREVSKNPDLQAIRIASVNPILDPWIYILLRKTVLSKAIEKIKCLFCRIGGSRRERSGQHCSDSQRTSSAMSGHSRSFISRELKEISSTSQTLLPDLSLPDLSENGLGGRNLLPGVPGMGLAQEDTTSLRTLRISETSDSSQGQDSESVLLVDEAGGSGRAGPAPKGSSLQVTFPSETLNLSEKCI Prostaglandin E2 receptor EP4 subtype PE2R4_HUMAN P35408 Q3MJ87